Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 18Rectal Neoplasms 10Colorectal Neoplasms 10Colonic Neoplasms 7Kidney Neoplasms 5Stomach Neoplasms 4Neuroblastoma 4Neoplasm Metastasis 4Liver Neoplasms 4Inflammatory Breast Neoplasms 4Carcinoma, Renal Cell 4Sarcoma 3Lung Neoplasms 3Gliosarcoma 3Glioblastoma 3Central Nervous System Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Intraductal, Noninfiltrating 3Carcinoma, Hepatocellular 3Brain Neoplasms 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Liposarcoma 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2Head and Neck Neoplasms 2Glioma 2Fibrosarcoma 2Esophageal Neoplasms 2

Interventions

Radiotherapy 2Ifosfamide 2HhAntag691 2Doxorubicin 2tanespimycin 1enasidenib 1alanosine 1Vincristine 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Radiotherapy, Conformal 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Neoadjuvant Therapy 1Gelclair 1Filgrastim 1Etoposide 1Epirubicin 1Dactinomycin 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Carboplatin 13-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Chondrosarcoma × Neoadjuvant Therapy × Clear all
NCT00334854 2013-08-12

Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
250 enrolled
Sarcoma

Hemangiopericytoma, Malignant, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Dermatofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡